We are live on ! Find out more
SSIA

Spero-Smith Investment Advisers Portfolio holdings

AUM $74.5M
1-Year Est. Return 12.27%
This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+12.27%
3 Year Est. Return
+31.25%
5 Year Est. Return
10 Year Est. Return
AUM
$80.6M
AUM Growth
+$36K
Cap. Flow
-$3.98M
Cap. Flow %
-4.94%
Top 10 Hldgs %
45.65%
Holding
43
New
1
Increased
5
Reduced
26
Closed
5

Top Buys

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$1.97M
2
CELG
Celgene Corp
CELG
+$90.4K
3
WFC icon
Wells Fargo
WFC
+$82K
4
CVX icon
Chevron
CVX
+$3.44K
5
AAPL icon
Apple
AAPL
+$1.86K

Sector Composition

Rank Sector Weight
1 Energy 24.02%
2 Healthcare 22.65%
3 Technology 22.37%
4 Communication Services 9.74%
5 Financials 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$655B
$12.6M 15.68%
146,788
-1,436
-1% -$129K
DHR icon
2
Danaher
DHR
$141B
$3.05M 3.78%
65,429
-2,953
-4% -$134K
HAR
3
DELISTED
Harman International Industries
HAR
$2.79M 3.46%
42,075
-145
-0.3% -$9.05K
MCK icon
4
McKesson
MCK
$106B
$2.68M 3.32%
20,866
-556
-3% -$68.3K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.08T
$2.67M 3.32%
122,497
-4,417
-3% -$97.6K
CELG
6
DELISTED
Celgene Corp
CELG
$2.62M 3.25%
34,000
+1,290
+4% +$90.4K
SNI
7
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$2.62M 3.25%
33,514
-1,175
-3% -$86.7K
FISV
8
Fiserv Inc
FISV
$29.6B
$2.61M 3.24%
103,316
-4,868
-4% -$118K
VTRS icon
9
Viatris
VTRS
$20.8B
$2.57M 3.19%
67,411
-28,900
-30% -$1.02M
NVS icon
10
Novartis
NVS
$299B
$2.54M 3.15%
36,894
-1,830
-5% -$121K
CVS icon
11
CVS Health
CVS
$138B
$2.52M 3.13%
44,389
-3,376
-7% -$201K
CERN
12
DELISTED
Cerner Corp
CERN
$2.4M 2.98%
45,715
-741
-2% -$36.1K
COP icon
13
ConocoPhillips
COP
$144B
$2.38M 2.96%
34,311
-1,794
-5% -$120K
WFC icon
14
Wells Fargo
WFC
$260B
$2.29M 2.84%
55,291
+1,921
+4% +$82K
TMO icon
15
Thermo Fisher Scientific
TMO
$215B
$2.27M 2.82%
24,686
-2,800
-10% -$253K
SRCL
16
DELISTED
Stericycle Inc
SRCL
$2.25M 2.79%
19,457
-1,090
-5% -$126K
ACN icon
17
Accenture
ACN
$106B
$2.22M 2.76%
30,143
-1,285
-4% -$95.1K
VZ icon
18
Verizon
VZ
$200B
$2.22M 2.76%
47,571
-1,836
-4% -$89.6K
HBAN icon
19
Huntington Bancshares
HBAN
$34.6B
$2.13M 2.65%
258,248
-18,489
-7% -$156K
IBM icon
20
IBM
IBM
$213B
$2.12M 2.63%
11,975
-582
-5% -$106K
MSFT icon
21
Microsoft
MSFT
$2.93T
$2.11M 2.62%
63,364
-1,030
-2% -$33.9K
ANSS
22
DELISTED
Ansys
ANSS
$2.08M 2.59%
24,100
-2,025
-8% -$169K
EMC
23
DELISTED
EMC CORPORATION
EMC
$1.94M 2.41%
+75,820
New +$1.97M
INTC icon
24
Intel
INTC
$425B
$1.88M 2.34%
82,152
-2,176
-3% -$50.1K
CVX icon
25
Chevron
CVX
$382B
$1.77M 2.2%
14,557
+28
+0.2% +$3.44K

Similar funds

Spero-Smith Investment Advisers's Q3 2013 Portfolio in Review

As of Q3 2013, Spero-Smith Investment Advisers held 43 positions worth $80.6M, up 0.04% from $80.5M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Spero-Smith Investment Advisers withdrew a net $3.98M in Q3 2013, closing 5 positions and reducing 26 holdings. Its most notable exit was Colgate-Palmolive, an estimated $1.56M position sold in full.

By sector, the portfolio is most concentrated in Energy at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Spero-Smith Investment Advisers opened a new position in EMC CORPORATION worth $1.94M.

  • Spero-Smith Investment Advisers's largest Q3 2013 buy was EMC CORPORATION: 75,820 shares worth $1.94M.
  • Spero-Smith Investment Advisers added most to Celgene Corp in Q3 2013, an estimated $90.4K increase.
  • Spero-Smith Investment Advisers's biggest Q3 2013 reduction was Viatris, cutting an estimated $1.02M.
  • Spero-Smith Investment Advisers fully exited Colgate-Palmolive in Q3 2013, selling an estimated $1.56M.
  • Spero-Smith Investment Advisers's ten largest holdings make up 46% of its $80.6M portfolio in Q3 2013.
  • Spero-Smith Investment Advisers opened 1 new position and closed 5 in Q3 2013.
  • Spero-Smith Investment Advisers's portfolio value rose 0.04% quarter-over-quarter to $80.6M.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2013, filed 12 Nov 2013.